Skip to Content

Copeland Dividend Growth Fund Class C CDCRX Fund Analysis

| Medalist Rating as of | See Copeland Funds Investment Hub

Morningstar’s Analysis CDCRX

Will CDCRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Copeland Dividend Growth Fund Class C's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers. The strategy changed its peer group last March, moving from the Large Blend category to the Mid-Cap Blend Morningstar Category.

Rated on Published on

Unlock our full analysis with Morningstar Investor